Retrospective cohort study of the efficacy and safety of dabigatran: real-life dabigatran use including very low-dose 75 mg twice daily administration

BACKGROUND: Dabigatran is a direct thrombin inhibitor and an anticoagulant that is prescribed to prevent ischemic stroke and systemic embolism in non-valvular atrial fibrillation. Dabigatran (150 mg twice daily) is non-inferior to warfarin for the prevention of stroke and systemic embolism. A dose r...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Pharm Health Care Sci
Auteurs principaux: Akagi, Yuuki, Chiba, Tatsuo, Uekusa, Shusuke, Kato, Hiroyoshi, Yamamura, Shigeo, Aoki, Yukiko, Enoki, Mizuho, Ogawara, Yuka, Kasahara, Takanori, Kimura, Yuki, Shimizu, Tadahiro, Takeishi, Aiko, Nakajima, Yuko, Kobayashi, Hideki, Sugi, Kaoru
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6670142/
https://ncbi.nlm.nih.gov/pubmed/31388437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-019-0145-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires